NASDAQ NMS - GLOBAL MARKET · BLFS
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
BioLife Solutions Inc

BioLife Solutions Inc

Life Sciences Tools & Services
$28.11

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is BLFS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About BioLife Solutions Inc
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Listed since
1989
Employees
155
Country
US

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$28.11
Last session
Day high
$28.11
Last session
Day low
$28.11
Last session
Previous close
$28.11
52W high
$28.67
-1.95% from high
52W low
$24.90
85% of range
Market cap
$1.4B
EPS
$-0.3100
Shares out
48.9M
VWAP
$28.11
Last session
Price history computed in-house
1W
-1.95%
SMA 50 $26.93 · above
SMA 200 $26.93 · above
52W position 85%
Veridion warehouse edge

Warehouse intelligence for BLFS.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

BLFS insider activity

BioLife Solutions Inc

Score
Coverage building
Pressure
Net selling
Filings
95
Buys / sells
0 / 95
Net value
-$86.3M
Insiders
10
Named filers
WS
Werner Sean
Insider
Leadership
WT
Wichterman Troy
Insider
Leadership
BT
Berard Todd
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$86.3M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-222026-06-18Werner SeanInsidersell$26.0442047,831$11KSEC Form 4
2026-06-222026-06-18Wichterman TroyInsidersell$26.04937214,093$24KSEC Form 4
2026-06-222026-06-18Berard ToddInsidersell$26.04470162,942$12KSEC Form 4
2026-06-222026-06-18Mathew Aby J.Insidersell$26.04564388,976$15KSEC Form 4
2026-06-222026-06-18DE GREEF RODERICKInsidersell$26.042,775730,971$72KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 90 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

BLFS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BLFS in this window.
Lobbying spend

BLFS lobbying filings, year to date.

Registered lobbying filings matched to BioLife Solutions Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BLFS in this window.
Latest news · BLFS
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for BLFS.
Options
Sovereign unlock shows live options positioning for BLFS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.